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Interleukin (IL)-1 is a proinflammatory cytokine implicated in various pathophysiological conditions of the CNS involving NMDA
receptor activation. Circumstantial evidence suggests that IL-1 and NMDA receptors can functionally interact. Using primary cultures
of rat hippocampal neurons, we investigated whether IL-1 affects NMDA receptor function(s) by studying (1) NMDA receptor-induced
[Ca2]i increase and (2) NMDA-mediated neurotoxicity. IL1 (0.01–0.1 ng/ml) dose-dependently enhances NMDA-induced [Ca
2]i
increases with a maximal effect of45%. This effect occurred only when neurons were pretreated with IL-1, whereas it was absent if
IL-1 and NMDA were applied simultaneously, and it was abolished by IL-1 receptor antagonist (50 ng/ml). Facilitation of NMDA-
induced [Ca2]i increase by IL-1 was prevented by both lavendustin (LAV) A (500 nM) and 4-amino-5-(4-chlorophenyl)-7-(t-
butyl)pyrazolo[3,4-d]pyrimidine (PP2) (1 M), suggesting an involvement of tyrosine kinases. Increased tyrosine phosphorylation of
NMDA receptor subunits 2A and 2B and coimmunoprecipitation of activated Src tyrosine kinase with these subunits was observed after
exposure of hippocampal neurons to 0.05 ng/ml IL-1. Finally, 0.05 ng/ml IL-1 increased by30% neuronal cell death induced by
NMDA, and this effect was blocked by both lavendustin A and PP2.
These data suggest that IL-1 increases NMDA receptor function through activation of tyrosine kinases and subsequent NR2A/B
subunit phosphorylation. These effects may contribute to glutamate-mediated neurodegeneration.
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Introduction
Interleukin (IL)-1, originally described as an immune cell me-
diator in the periphery, has been involved in the modulation of
several neurological functions and dysfunctions (Rothwell and
Hopkins, 1995; Viviani et al., 2001). Thus, administration of the
naturally occurring antagonist of IL-1, namely IL-1 receptor an-
tagonist (IL-1ra), impairs long-term potentiation (Schneider et
al., 1998), attenuates normal spontaneous sleep (Takahashi et al.,
1996), inhibits motor and electroencephalographic seizures
(Vezzani et al., 2000), and reduces neuronal damage caused by
ischemic, excitotoxic, and traumatic brain injury (Yamasaki et
al., 1995; Loddick and Rothwell, 1996; Allan et al., 2000). In ad-
dition, these physiological and pathological conditions are asso-
ciated with an increased expression of IL-1 in the brain (Taishi
et al., 1997; Schneider et al., 1998; Vezzani et al., 1999, 2000; Allan
and Rothwell, 2001). Recent studies showed that IL-1 affects
various classic neurotransmitter systems (Rothwell andHopkins,
1995; Grazia de Simoni and Imeri, 1998). Substantial evidence
suggests the existence of a reciprocal functional interaction be-
tween IL-1 and NMDA receptors (NMDARs). Thus, intracere-
bral injection of NMDA in perinatal rat brain stimulates the pro-
duction of IL-1 (Hagan et al., 1996) and in adult rat brain IL-1
exacerbates the neuronal damage induced by NMDA application
(Loddick and Rothwell, 1996). In addition, intrahippocampal
injection of IL-1 induces proconvulsant actions in rats that are
blocked by selective antagonism of NMDA receptors (Vezzani et
al., 1999).
NMDA receptors are glutamate-gated ion channels consisting
of an essential subunit, NR1, and one or more components of a
second family of subunits termed NR2A–D (Hollmann and Hei-
nemann, 1994) and NR3A/B (Chatterton et al., 2002). NMDA
channel activity is modulated by phosphorylation by several ki-
nases: protein kinase A (PKA) and protein kinase C (PKC) phos-
phorylate NR1, NR2A, and NR2B subunits at serine–threonine
sites (Leonard and Hell, 1997); calcium/calmodulin-dependent
protein kinase II (CaMKII), which is part of the NMDA receptor
complex (Gardoni et al., 1998), as well as the Src family of kinases
phosphorylate NR2A and NR2B (Moon et al., 1994; Lau and
Huganir, 1995; Omkumar et al., 1996; Gardoni et al., 1998).
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Phosphorylation at tyrosine residues by the Src family of kinases
leads to NMDA current increase (Yu et al., 1997), whereas de-
phosphorylation by tyrosine phosphatases determines a decrease
in the probability of NMDA channel openings (Wang and Salter,
1994). Furthermore, recent evidence indicates that PKC action
may involve the activation of protein tyrosine kinase 2 signaling
cascade upstream of Src kinase (Lu et al., 1999; Grosshans and
Browning, 2001). The Src family of kinases therefore plays a cen-
tral role in the modulation of the NMDA function.
In this study, we investigated whether IL-1 enhances NMDA
receptor function and the involvement of the Src family of ty-
rosine kinases in this process. For this purpose, we studied the
effect of IL-1 on (1) intracellular Ca2 increase induced by
NMDA receptor activation and (2) the phosphorylation of
NMDA receptorNR2A/B subunits using primary cultures of hip-
pocampal neurons. Finally, to evaluate the functional conse-
quences of IL-1 and NMDA receptor interactions, we studied
whether IL-1 increased NMDA-mediated neuronal death in
vitro.
Materials andMethods
Primary cultures of hippocampal neurons. Neuronal cultures were estab-
lished from the hippocampus of 18-d-old rat fetuses. Briefly, brains were
removed and freed from meninges, and the hippocampus was isolated.
Cells were then dispersed by incubation for 5 min at 37°C in a 2.5%
trypsin solution followed by trituration. The cell suspension was diluted
in Neurobasal media supplemented with 1% B-27 (Life Technologies,
Rockville, MD) and plated on polyornithine-coated coverslips at a den-
sity of 80,000 cells per coverslip. For immunocytochemistry, dissociated
rat hippocampal neurons were grown using the Goslin and Banker
method (1998). Both of these culture conditions allowed us to grow
differentiated neuronal cultures with96% homogeneity, as assessed by
immunocytochemistry of microtubule-associated protein 2 and glial
fibrillary acidic protein (Molecular Probes, Eugene, OR). Hippocampal
neurons were used after a culturing period of 10–14 d.
IL-1 and drug applications. Rat recombinant IL-1 (Sigma, St. Louis,
MO) was used in all of the experiments. Neurons were exposed to drugs
in HBSS containing (inmM): 137 NaCl, 5.4 KCl, 1.8 CaCl2, 4.2 NaHCO3,
5 glucose, 10 HEPES. Tomeasure the effect of IL-1 onNMDA-induced
[Ca2]i increase, IL-1 (0.01–1 ng/ml) was added together with or 6min
before 10 M NMDA applied for 3 min. Lavendustin A (500 nM) and 1
M 4-amino-5-(4-chlorophenyl)-7-(t-butyl)pyrazolo[3,4-d]pyrimidine
(PP2) (30 min) (Calbiochem, La Jolla, CA), 50 ng/ml human recombi-
nant IL1ra (15 min) (a generous gift from Dr. P. Ghezzi, Mario Negri
Institute, Milan, Italy), 50 M 2-aminoethoxydiphenylborane (2-APB)
plus 10 M dantrolene (10 min), 1 M nitrendipine, and 1 M tetrodo-
toxin (2 min) (Tocris, Bristol, UK) were preincubated with neurons at
the times shown in parentheses before addition of IL-1 and kept in the
incubation medium during subsequent stimulation with NMDA.
MK801 (10 M) (Tocris) was added 1.5 min after NMDA stimulation.
Control neuronal cultures were run in parallel in each experimental con-
dition and incubated for the appropriate times in HBSS.
Determination of the cytosolic free Ca2 concentration [Ca2]i. Neurons
were loaded with 10 M fura-2 AM (Sigma) for 1 hr at 37°C in their
culture medium supplemented with 1% bovine serum albumin, 0.1%
pluronic (Sigma). [Ca2]i measurement was performed in HEPES
buffer, pH 7.4, as described previously (Viviani et al., 2001).
The fura-2 fluorescence ratio signal was measured in a Perkin-Elmer
LS 50 B double-wavelength fluorimeter and calibrated in terms of
[Ca2]i.
Immunocytochemistry and confocal imaging. Coverslips containing
neurons were lifted from the astrocytemonolayer, washed by immersion
in PBS, and fixed in ice-cold 4% paraformaldehyde (Merck, Darmstadt,
Germany) for 30 min. The coverslips were then incubated for 10 min at
room temperature in PBS containing 0.25%TritonX-100 (Sigma). Non-
specific sites were blocked by incubation in PBS containing 10% normal
goat serum. For double immunostaining, the coverslips were incubated
in 2% normal goat serum containing a 1:500 dilution of a rabbit poly-
clonal antibody against NR2A/B and a hamster monoclonal antibody
against IL-1RI for 2 hr at 37 C. Specific binding was detected using
Figure 1. IL-1 effect on NMDA-induced [Ca 2]i increase in primary cultures of hippocam-
pal neurons. A, Bar graph represents the average peak Ca 2 response to the application of 10
MNMDAaloneor in thepresenceof increasing concentrationof IL-1. Values are themean
SE of 7–13 independent samples. Percentage values represent the IL-1 effect expressed as
percentage increase () or decrease () of the NMDA response measured in the absence of
IL-1. Hippocampal neurons were exposed to IL-1 (0.01–1 ng/ml) for 6 min and subse-
quently stimulatedwith 10MNMDA. [Ca 2]i increasewas determined by loading hippocam-
pal neurons with fura-2 AM and measuring fura-2 fluorescence ratio signal in a double-
wavelength fluorimeter. **p  0.01; *p  0.05 versus NMDA alone; ANOVA followed by
Tukey’s test. B, Representative Ca 2 traces showing the response of hippocampal neurons
exposed to 10M NMDA alone or with 6 min pretreatment with 0.05 ng/ml IL-1. C, Repre-
sentative Ca 2 trace showing the rapiddecay in the responseof hippocampal neuronswhen10
M MK801 was applied 1.5 min after NMDA stimulation. Neurons were exposed for 6 min to
0.05 ng/ml IL-1 and then stimulated with 10M NMDA.
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secondary antibodies conjugated to AlexaFluor dyes (594: red, for IL-
1RI; 647: blue for NR2A/B) (Molecular Probes). Images were collected
on a Delta Vision Optical SectioningMicroscope consisting of an Olym-
pus IX-70 microscope equipped with a mercury arc lamp. A photomet-
rics CH 350 cooled CCD camera and a high-precision motorized XYZ
stage were used to acquire multiple consecutive optical sections at a 0.2
m interval for each of the fluorescent probes. AUPAPLO60 objective
was used to collect the images.
Metabolic labeling and immunoprecipitation. Hippocampal cultures
were preincubated for 2 hr in phosphate-free minimal essential medium
(Sigma) and then labeled with [ 32P]orthophosphate (0.5 mCi/ml; Am-
ershamBiosciences, Buckinghamshire, UK) in the samemedium for 2 hr
at 37°C. The cultures were pretreated for 30minwith 500 nM lavendustin
A or 1M PP2 or HBSS (control) and then incubated for 6min with 0.05
ng/ml IL-1. After two quick washes with cold HBSS, the cells were
harvested into 0.5 ml of ice-cold solubilization buffer containing 50 mM
HEPES, pH 7.4, 0.5 M NaCl, 0.5% Triton X-100, 0.1% deoxycholate, 1
mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10 mM NaF, in the
presence of a complete set of proteases inhibitors (Complete, Boehringer
Mannheim, Mannheim, Germany). Each solubilized sample was incu-
bated overnight with NR2A/B polyclonal antibody and then for 2 hr at
4°C with protein A-Sepharose beads. After this incubation, the superna-
tants were removed, and the beads were washed five times with solubili-
zation buffer. After the final wash, the beads were resuspended in SDS
sample buffer and centrifuged briefly; the supernatants were loaded on
7% SDS-PAGE gels.
To quantify 32P incorporation in NR2A/B, the optical density of the
band corresponding to the 170 kDaNR2A/B-receptor subunits wasmea-
sured on autoradiograms, and the values were corrected for the amount
of 32P incorporation in total proteins. To this aim, aliquots of neuronal
homogenates were spotted on P81 paper and analyzed for total 32P pro-
tein. The results were then expressed in each experiment as a percentage
of control values. Western blot analysis was performed by computer-
assisted imaging (Quantity-One System; Bio-Rad, Richmond, CA).
Surface expression experiments. Cultures were biotinylated bymeans of
the reversible membrane impermeable derivate of biotin sulfo-NHS-S-
S-biotin (Pierce, Rockford, IL) (1 mg/ml) for 15 min at 37°C; unreacted
biotinylation reagents was quenched by three successive 5 min washes in
ice-cold TBS (50 mM Tris-HCl, pH 7.5, 200 mM NaCl). Cells were har-
vested in TBS containing 2 mM EDTA, 2 mM EGTA, and pelleted at
14,000  g for 30 min. Cell pellet was lysed and sonicated in 50 mM
HEPES, pH 7.5, 0.1 mM EDTA, 1% Triton X-100 in the presence of a
complete set of protease inhibitors (Complete, Boehringer Mannheim)
and phosphatase inhibitors. Cell lysates were cleared by centrifugation at
14,000  g for 15 min. UltraLink immobilized NeutrAvidin beads
(Pierce) was added to the supernatant, and the samples were rotated at
4°C for 2 hr. Next the NeutrAvidin beads were washed five times with
lysis buffer, and bound proteins were eluted into SDS sample buffer by
boiling for 15 min. Biotinylated proteins were resolved by SDS-PAGE
and subjected to immunoblot analysis with IL1-R1 antibody.
Reverse transcriptase-PCR. Total RNA was isolated using a commer-
cially available single-step isolation kit (Trizol, Invitrogen, Paisley, UK)
and extracted following supplier’s instructions. Reverse transcriptase
(RT)-PCR reactions were performed as described previously (Viviani et
al., 2001). PCR primers for IL-6 and glyceraldehyde-6-phosphate dehy-
drogenase (GPDH)were synthesizedbyPrimm(Milan, Italy) andcontained
the following sequences: IL-6 sense, 5-ATGAAGTTCCTCTCTGCAA-
GAGACT-3; IL-6antisense, 5-CACTAGGTTTGCCGAGTAGATCTC-3;
GPDH sense, 5-TGAAGGTCGGAGTCAACGGATTT-3; GPDH anti-
sense, 5-CATGTGGGCCATGAGGTCCACCAC-3.
The amplified PCRproducts are 638 bp for IL-6 and 983 bp forGPDH.
In preliminary experiments, RNA concentrations and PCR cycles were
titrated to establish standard curves to document linearity and permit
semiquantitative analysis of signal strength (80 and 200ng forGPDHand
IL-6, respectively). The PCR was conducted using a Perkin Elmer ther-
mocycler, with the following conditions: 35 cycles of denaturation at
95°C for 30 sec, annealing at 65°C for 30 sec, extension at 72°C for 30 sec,
followed by a final 7 min extension at 72°C. The PCR products were
visualized by UV illumination after electrophoresis through 1.5% aga-
rose at 80 V and staining in 1 TBE buffer containing 0.5 g/ml
ethidium bromide. Gels were photographed with type 667 film (Po-
laroid, Cambridge, MA). The image of the PCR products was acquired
with a Nikon CCD video camera module (Nikon, Melville, NY). The
optical density of the bands was calculated, and peak area of a given band
was analyzed by means of the Image 1.61 program for digital image
processing (Wayne Rasband, Research Service Branch, National Insti-
tutes of Health, Bethesda, MD).
Antibodies. Antibody against NR2A/B was purchased from Chemicon
International (Temecula, CA); p1472-NR2B antibody was purchased
Figure 2. Duration of the IL-1 effect on NMDA-induced [Ca 2]i increase. A, Trace 1 (gray)
depicts a representative Ca 2 trace showing the response of hippocampal neurons to four
consecutive applications of 10MNMDA, the first in thepresence (6minpreincubation) and the
following in the absence of 0.05 ng/ml IL-1. Trace 2 (black) depicts a representative Ca 2
trace showing the response of hippocampal neurons to four consecutive applications of 10M
NMDA done in the absence of IL-1. Intracellular Ca 2 increase was determined by loading
hippocampal neurons with fura-2 AM and measuring fura-2 fluorescence ratio signal in a
double-wavelength fluorimeter. B, Average peak Ca 2 response to four consecutive applica-
tions of NMDA as reported in A. Values are the mean SE of 13 independent samples. **p
0.01 and *p 0.05 versus control; ANOVA followed by Tukey’s test.
Table 1. IL-1 effect on NMDA-induced [Ca2]i increase in hippocampal neurons
pretreated with TTX, nitrendipine, or 2-APB and dantrolene
[Ca2]i (nM)
10M NMDA
0.05 ng/ml IL-1
 10M NMDA
None 143 3.7 193 6.6
1M TTX 142 18 199 25.2
1M Nitrendipine 133 23.5 182 10.4
50M 2-APB 10M dantrolene 141 7.5 200 11.7
Values are means SE of four independent samples and represent the average peak Ca2 response. TTX (1M, 2
min), nitrendipine (1 M, 2 min) and APB (50 M), plus dantrolene (10 M, 10 min) were preincubated with
neurons at the times shown in parentheses before the addition of 0.05 ng/ml IL-1 and kept in themedium during
subsequent stimulation with 10M NMDA.
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from Calbiochem; p416-active-Src monoclonal antibody was purchased
from Alexis (Lausen, Switzerland); IL-1RI (clone JAMA-147) was pur-
chased from PharMingen (San Diego, CA); IL-1RI and NR2A/B second-
ary antibodies conjugated to AlexaFluor dyes were from Molecular
Probes.
Viability assay. For viability assays, neuronswere pretreated for 30min
with 500 nM lavendustin A or 1 M PP2 or HBSS and then exposed to 10
MNMDA only or to 0.05 ng/ml IL-1 for 6min and subsequently to 10
M NMDA for 3 hr. Finally, all drugs were removed and neurons were
returned to their culture medium for 24 hr. Cell viability was measured
by the 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT) assay (Denizot and Lang, 1986). Briefly, MTT tetrazolium salt
was dissolved in serum-free medium to a final concentration of 0.75
mg/ml and added to the cells before the end of the experiment for 3 hr at
37°C. The medium was then removed and the formazan was extracted
with 1N HCl/isopropanol (1:24). Absorbance at 560 nm was read on a
Multiscan reader.
Statistical analysis. The statistical significance of differences was deter-
mined by one-way or two-way ANOVA followed by a multiple compar-
ison test (Tukey’s test). A significance level of 95% ( p  0.05) was
accepted.
Results
IL-1 effect on NMDA-induced intracellular Ca2 ([Ca2]i )
increase in primary cultures of hippocampal neurons
[Ca2]i increase induced by NMDA was used as a well estab-
lished index of functional activation of this receptor. To evaluate
whether IL-1modulates the NMDA receptor function, primary
cultures of hippocampal neurons were pre-exposed to increasing
concentrations of IL-1 (0.01–1 ng/ml) and subsequently stim-
ulated with 10 M NMDA (Fig. 1). Pre-exposure of neurons to
IL-1 at the above concentrations did not affect basal [Ca2]i
levels, which were between 67  9.7 and 75  3.4 nM in the
presence of IL-1, and 73 5.3 nM in the absence of IL-1.
[Ca2]i increase induced by 10MNMDAwas enhanced by 6
min preincubation with IL-1 in a dose-dependent manner (Fig.
1A). Thus, 0.025–0.1 ng/ml IL-1 enhanced NMDA-induced
response, reaching a maximal effect (45  2.36%; n 	 13) at
0.05 ng/ml (Fig. 1A,B). Higher concentrations of IL-1 (0.25–
0.5 ng/ml) were ineffective, whereas 1 ng/ml was slightly inhibi-
tory (Fig. 1A).
We then focused our attention on the facilitating action of
IL-1 on NMDA-induced response, because this effect could ex-
plain several of the in vivo actions of this cytokine.
The potentiating effect of IL-1 on NMDA-induced increase
in [Ca2]i was caused predominantly by Ca
2 influx through the
NMDA receptor channel. This is supported by the following ev-
idence: (1) 10 M MK801, an open channel blocker that binds
only to activated NMDA receptors, when added 1.5 min after
NMDA application in IL-1  (0.05 ng/ml) pretreated neurons,
sharply reduced [Ca2]i to resting levels (Fig. 1C); (2) pretreat-
ment of neurons with 1 M TTX, which blocks sodium channels
Figure 3. Immunofluorescence of IL-1RI and NR2A/B subunits of the NMDA receptor in
primary cultures of hippocampal neurons. Detection of IL-1RI and NR2A/B subunits was ob-
tained by double immunostaining with specific antibodies (see Materials and Methods) and
AlexaFluor-conjugated secondary antibodies. Images were collected on a Delta Vision Optical
Sectioning Microscope. IL-1RI and NR2A/B subunits are localized on the same neurons and
showed a similar distribution pattern.
Figure 4. Involvement of tyrosine kinases in IL-1 facilitation of the NMDA response. A,
Hippocampal neurons were exposed simultaneously to 0.05 ng/ml IL-1 and 10 M NMDA
(dotted column) or pretreated for 6minwith 0.05ng/ml IL-1 and then stimulatedwith 10M
NMDA (black column). Values are means SE of five independent samples and represent the
average peak Ca 2 response. **p 0.01 versus control; ANOVA followed by Tukey’s test. B,
Average peak Ca 2 increase as percentage of the NMDA response in control neurons laven-
dustinAorPP2and in IL-1-pretreatedneurons lavendustinAorPP2.Hippocampalneurons
were pretreated with 500 nM lavendustin A or 1M PP2 for 30min and then exposed to NMDA
aloneor 0.05ng/ml IL-1 for 6minand subsequently stimulatedwith10MNMDA.Values are
means SE of five independent samples. **p 0.01 versus IL-1 plus NMDA; ANOVA followed
by Tukey’s test.
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and neurotransmission, or nitrendipine,
an L-type voltage-gated Ca2 channel
blocker, did not modify IL-1 potentia-
tion of NMDA-induced [Ca2]i increase
(Table 1); (3) pretreatment with 10 M
dantrolene, an antagonist of ryanodine re-
ceptor, together with 50M 2-APB, an IP3
receptor antagonist, did not alter IL-1
enhancing effect (Table 1), thus suggesting
that both IP3-sensitive and -insensitive
Ca2 stores are not involved in IL-1 ef-
fect; and (4) finally, a contribution of
Ca2-permeable AMPA receptors attrib-
utable to a secondary release of glutamate
was excluded, because AMPA response
was not potentiated by IL-1 (AMPA 100
M: 147  8.7 nM; IL-1 plus AMPA 100
M: 141  12 nM; n 	 5). The classic
AMPA receptor inhibitors 2,3-dioxo-6-
nitro-1,2,3,4-tetrahydrobenzo[f]quinox-
aline-7-sulfonamide and CNQX could not
be used to exclude AMPA receptor-medi-
ated effects, because of their interference
with the fura-2 fluorescent signal.
To study whether IL-1modulation of
the NMDA response was reversible after
removal of this cytokine, hippocampal
cells, with or without 6 min pretreatment
with IL-1, were washed in fresh HBSS af-
ter 3 min NMDA application (Fig. 2A).
Removal of NMDA in control neurons or
of IL-1 plus NMDA in IL-1-pretreated
neurons resulted in a rapid drop of
[Ca2]i to basal levels (Fig. 2A). The same
neurons were then exposed to 10 M
NMDA alone for three consecutive times. [Ca2]i was enhanced
to a lesser extent compared with the immediately preceding
NMDA application (Fig. 2A,B); however, NMDA-induced
[Ca2]i was significantly higher in neurons pre-exposed once to
IL-1 (Fig. 2, trace 1) than in control neurons (Fig. 2, trace 2).
This indicates that the potentiating effect of IL-1 lasts for at least
24 min even in the absence of this cytokine (Fig. 2B).
Effect of IL-1ra on IL-1 potentiation of NMDA
receptor function
IL-1 exerts its actions by binding to IL-1 receptor type I (IL-1RI)
(Dinarello, 1996). To assess whether the effect of IL-1 on
NMDA receptor was receptor mediated, hippocampal neurons
were incubated for 5 min with 50 ng/ml IL-1ra before treatment
with 0.05 ng/ml IL-1 and the subsequent stimulation with
NMDA. IL-1ra per se did not affect NMDA-induced [Ca2]i (10
MNMDA: 133 7.5 nM; IL-1ra plus NMDA: 136 17 nM; n	
5) but prevented IL-1-induced potentiation of the NMDA re-
sponse (0.05 ng/ml IL-1 plus NMDA: 190 10 nM; IL-1ra plus
IL-1  NMDA: 126  11.4 nM; n 	 5). Double labeling of
hippocampal neurons with specific antibodies against NMDA
receptor 2A/B subunits and IL-1RI (Fig. 3, IL-1 RI, red, and NR
2A/B, green) showed that these neurons express both receptors
with a similar distribution pattern, thus further supporting the
possibility that IL-1 actions onNMDA receptors occur through
IL-1RI.
IL-1 and tyrosine kinase-dependent phosphorylation of
NMDA receptors
Potentiation of the NMDA response by IL-1 required that hip-
pocampal neurons were exposed to 0.05 ng/ml IL-1 before
NMDA addition; thus their simultaneous application did not
enhance NMDA effect (Fig. 4A). This suggests that activation of
intracellular cascade(s) downstream to IL-1 and IL-1RI inter-
action ismandatory tomediate this effect. In accordance with the
involvement of Tyr-phosphorylation processes, we found that
pretreatment of hippocampal neurons with lavendustin A (500
nM), a tyrosine kinase inhibitor, or the Src family tyrosine kinase
inhibitor PP2 (1 M) prevented IL-1 enhancement of NMDA-
mediated [Ca2]i rise, without affecting the NMDA response per
se (Fig. 4B). To investigate whether NR2A/B subunits were phos-
phorylated in the presence of IL-1, hippocampal neurons were
labeled with [32P]orthophosphate and exposed to 0.05 ng/ml
IL-1 for 6 min. 32P incorporation was quantified on neuronal
lysate by immunoprecipitation with a polyclonal antibody raised
against NR2A/B. Our data show that IL-1 treatment of hip-
pocampal neurons significantly increased the phosphorylation of
NMDA receptor subunitsNR2A/B, and this effect was blocked by
either lavendustin A or PP2 (Fig. 5A,B).
Among tyrosine kinases, the nonreceptor Src family tyrosine
kinases have been implicated in NR2A and NR2B subunit phos-
phorylation (Yu et al., 1997). Under our experimental condi-
tions, immunoprecipitation of NR2A/B induces coprecipitation
of a phosphorylated band at65 kDa (Fig. 5C,D), corresponding
to the phosphorylated members of the Src family as reported
Figure5. IL-1-induced phosphorylation of NR2A/B subunits through the Src family of tyrosine kinases.A, Metabolic labeling
and immunoprecipitation of NR2A/B subunits. Hippocampal neurons were incubated for 30min in HBSS plus 500 nM lavendustin
A (LAV) or 1M PP2 and then exposed to 0.05 ng/ml IL-1 for 6 min. Controls (C) were hippocampal neurons incubated in HBSS
for 36 min. B, Histogram shows the 32P incorporation in NR2A/B subunits in the various experimental conditions, expressed as
percentage of control. Values were normalized as reported in Materials and Methods. Lavendustin and PP2 alone were not
different from the control. Values aremean SE (n	6). **p0.01 IL-1 versus control; §§ p0.01 IL-1 LAVand IL-1PP2
versus IL-1 by ANOVA followed by Tukey’s test. C, Representative autoradiography showing the presence of a phosphorylated
protein bandof apparentmolecularweight 65 kDa in anti-NR2A/B immunoprecipitates (arrowhead).Molecularweight standards
are reported to the left. D, Histograms shows 32P incorporation in a 65 kDa phospho-band in the various experimental conditions,
expressed as percentage of control. Values were normalized as reported in Materials and Methods. Lavendustin and PP2 alone
were not different from the control. Values aremean SE (n	 6). **p 0.01 IL-1 versus control; §§ p 0.01 IL-1 LAV and
IL-1 PP2 versus IL-1 by ANOVA followed by Tukey’s test.
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previously (Yu et al., 1997; Gardoni et al., 2002). 32P incorpora-
tion into this band was induced by IL-1 and completely blocked
by pretreatment with either lavendustin A or PP2. Src family mem-
bers Sre activated after Tyr416 phosphorylation in the autocatalytic
site (Cooper andMacAuley, 1988). Six minutes of exposure to 0.05
ng/ml IL-1 significantly increased the amount of phosphorylated
Tyr416-Src coimmunoprecipitatedwith theNR2A/B subunits (Fig.
6A,B) as revealed by an anti-phospho-Tyr416 Src antibody. As
expected, both lavendustin A and PP2 were able to block Tyr416
phosphorylation. No difference in NR2A/B immunoreactivity
was observed among the various treatments (Fig. 6A).
Several tyrosine residues in the C-terminal cytoplasmic region
of NR2B have been shown to be phosphorylated by Src family
tyrosine kinases in vitro (Nakazawa et al., 2001). Among these,
Tyr-1472 is the major phosphorylation site. Using a well charac-
terized antibody to phospho-Tyr-1472 (Nakazawa et al., 2001),
we next investigated whether this particular tyrosine phospho-
site was modulated by IL-1 treatment. As shown in Figure 6C,
IL-1 induced NR2B Tyr-1472 phosphorylation (Fig. 6D), and
this effect was blocked by either lavendustin A or PP2. The total
amount of NR2B protein was not modified by the various
treatments (Fig. 6C).
By using membrane-impermeant biotinylation techniques,
we found that the IL1-R1 concentration on the cell surface was
not affected by either lavendustin (89.2  14.1%; LAV vs con-
trols) and PP2 (92.4 20.5%; PP2 vs controls) (Fig. 7), therefore
excluding a direct role of tyrosine kinase inhibitors on IL1-R1
receptor availability.
To exclude the possibility that the Src family of tyrosine ki-
nases could directly facilitate IL-1RI–me-
diated signal transduction, we studied the
effect of the selective Src family kinases in-
hibitor PP2 on IL-1-induced IL6 expres-
sion. Hippocampal neurons were pre-
treated for 30min with 1M PP2 and then
exposed for 6 min to 0.05 ng/ml IL-1.
IL-6 mRNA expression was measured 3 hr
later by RT-PCR. As shown in Figure 8,
IL-1 strongly increased IL-6 mRNA ex-
pression in hippocampal neurons and PP2
did not alter this effect.
IL-1 effect on NMDA-induced
neuronal death
We studied whether IL-1 potentiation of
NMDA-induced [Ca2]i increase results
in an enhancement of NMDA-mediated
death of hippocampal neurons. Treatment
of hippocampal neurons with 10 M
NMDA for 3 hr resulted in20% of neu-
ronal death over the next 24 hr (Fig. 9).
Pre-exposure of neurons for 6 min to 0.05
ng/ml IL-1 had no toxic effects per se but
significantly increased NMDA-induced
neuronal death, and this effect was pre-
vented by pretreatmentwith 500 nM laven-
dustin A or 1MPP2 (Fig. 9). Lavendustin
A and PP2 reduced NMDA-triggered neu-
ronal cell death in IL-1-pretreated neu-
rons below control values, but this effect
was not significant.
Discussion
The major finding of this study is that IL-1 induces tyrosine
phosphorylation of NR2A/B subunits of the NMDA receptor in
hippocampal neurons. In accordance with data showing that the
activation of this pathway enhances NMDA receptor-mediated
Ca2 fluxes (Wang and Salter, 1994), we observed that (1) con-
centrations of IL-1 that trigger NMDA receptor phosphoryla-
tion also facilitate NMDA-induced [Ca2]i increase and (2) both
lavendustin A, an inhibitor of the tyrosine kinase pathway, and
PP2, a more specific inhibitor for the Src family of tyrosine ki-
nase, prevents this effect.
The potentiation of NMDA response occurs via increased
Ca2 entry through the receptor-associated ion channel because
MK-801, a blocker that binds only to activated NMDA receptors,
inhibited this effect. In addition, AMPA receptors, voltage-
dependent Ca2 channels, intracellular Ca2 stores, or neuro-
transmitters released by neuronal depolarization do not appear
to play any significant role inmediating the effect of IL-1, which
remained unchanged in the presence of specific blockers of these
pathways.
IL-1-mediated potentiation of the NMDA receptor function
persists for several minutes after removal of this cytokine. This
evidence therefore suggests that even a transient exposure of neu-
rons to this cytokine may favor long-lasting activation of the
NMDAR function. This may have functional relevance for either
neuronal excitability or excitotoxicity. Thus, our results suggest
that hippocampal neurons exposed to IL-1 aremore susceptible
to glutamatergic excitation through the NMDA receptor compo-
nent. This may give insights into the molecular mechanisms un-
Figure 6. IL-1-induced phosphorylation of Src-Tyr-416 and NR2B-Tyr-1472. A, Proteins from hippocampal cell lysates were
immunoprecipitated (IP) with a polyclonal antibody raised against NR2A/B. Western blot was done in the immunoprecipitated
material using the NR2A/B antibody (top) or the phospho-specific p416Src antibody (bottom). Histograms in B show the quanti-
fication of the Tyr416-phosphorylated Src coimmunoprecipitated with the NR2A/B subunits. Data are normalized for NR2A/B
immunoreactivity. Values are mean  SE of two independent experiments (**p  0.01 IL-1 vs control; § p  0.05
IL-1  LAV and IL-1  PP2 vs IL-1; ANOVA followed by Tukey’s test). C, Representative Western blot depicting increased
phosphorylationofNR2B-Tyr-1472after exposure to IL-1 (bottom).D, Quantificationof Tyr-1472phosphorylation in the various
experimental conditions. Data are normalized for NR2A/B immunoreactivity (top) in the respective samples, which did not differ
among treatments. Values are mean SE (n	 6) obtained from two experiments, each including three independent samples
(**p 0.01 IL-1 vs control; § p 0.05 IL-1 LAV and IL-1 PP2 vs IL-1; ANOVA followed by Tukey’s test).
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derlying several of the in vivo effects exerted by this cytokine in
the hippocampus. In particular, the recent observation that IL-1
prolongs seizure activity in vivo and this effect is blocked by a
selective NMDA receptor antagonist (Vezzani et al., 1999) is
compatible with the present findings. Our results also support
previous in vivo evidence suggesting that this cytokine is a patho-
genic mediator of ischemic, traumatic, or excitotoxic brain dam-
age in rats, which are pathological conditions that depend pri-
marily on NMDA receptor function (Yamasaki et al., 1995;
Loddick and Rothwell, 1996). Thus, we show that concentrations
of IL-1 that cause NMDA receptor phosphorylation and poten-
tiate NMDA-induced [Ca2]i increase also exacerbate NMDA-
induced neuronal death.
With regard to the specific molecular pathway that mediates
IL-1 effect on NMDA receptor function, we provide evidence
for the involvement of the Src family of kinases. Src and Fyn are
leadmembers of a family of protein tyrosine kinases expressed in
the CNS that is involved in NR2A/B subunit phosphorylation
and the consequent functional upregulation of NMDA receptors
(Moon et al., 1994; Kohr and Seeburg, 1996; Lu et al., 1999).
Accordingly, lavendustin A and PP2 prevented both IL-1-
induced 32P incorporation intoNR2A/B subunits and phosphor-
ylation of the Src family specific NR2B-Tyr-1472 site, and they
blocked the enhanced NMDA-dependent Ca2 influx.
It is unlikely that the Src family of tyrosine kinases may di-
rectly facilitate IL-1RI signal transduction thereby modulating
IL-1 effect. Thus, Hazeki et al. (2003) reported that PP2 does
not affect IL-1 receptor-associated kinase (a serine–threonine ki-
nase) activity after MyD88 recruitment by Toll-like receptors. In
addition, we found that PP2 did not affect the expression of IL6
mRNA induced by IL-1 in hippocampal neurons. Thus, the Src
family of kinases appears to be selectively involved in the down-
stream cascade of events resulting in IL-1 potentiation of
NMDAR functions.
Activation of tyrosine kinases appears to be a crucial pathway
for the occurrence of neuronal cell death in the presence of IL-1
plus NMDA, because lavendustin A and PP2 prevented IL-
1mediated potentiation of neuronal damage. Accordingly, ty-
rosine phosphorylation of the NMDA receptor has been previ-
ously implicated in exacerbation of neuronal cell loss induced by
the human immunodeficiency virus-1 protein Tat (Haughey et
al., 2001) or by zinc (Manzerra et al., 2001), and receptor phos-
phorylation is increased after ischemic brain damage (Takagi et
al., 1997).
It should be noted that this pathway is also involved in phys-
iological functions mediated by NMDA receptors, such as the
induction of LTP (Salter, 1998) and the regulation of gene tran-
Figure 7. IL-1RI surface expression after lavendustin and PP2 exposure. Hippocampal neu-
ronswere preincubated for 30minwith HBSS plus 500 nM lavendustin A or 1M PP2 or to HBSS
for 30min (control). IL-1RI surface expressionwasmeasured bymembrane-impermeant bioti-
nylation techniques. A, Representative Western blot showing IL-1RI cell surface expression in
the various experimental conditions. Histograms in B show the quantification of IL-1RI concen-
trations on cell surface in the various experimental conditions. Data are normalized for IL-1RI
concentrations in the total cell lysates. Values are mean SE of three independent samples.
Figure 8. Lack of effect of PP2 on IL-1-induced IL-6 mRNA expression. Hippocampal neu-
rons were preincubated for 30 min with HBSS 1M PP2 and then exposed to 0.05 ng/ml
IL-1 for 6min. Control neuronswere exposed to HBSS for the duration of the experiment. IL-6
mRNA expression was measured 3 hr later by RT-PCR.
Figure 9. IL-1 effect on NMDA-induced neurotoxicity. Hippocampal neurons were prein-
cubated for 30minwith HBSS 500 nM lavendustin A or 1M PP2 and then exposed to NMDA
only or to0.05ng/ml IL-1 for 6minand subsequently to10MNMDA for 3hr. Control neurons
were exposed to HBSS for the duration of the experiment. At the end of this period, neurons
were returned to conditioned culture medium for 24 hr. MTT test was performed to assay cell
viability. Theenhancingeffect of IL-1onNMDA-inducedneuronal cell deathwaspreventedby
both lavendustin A and PP2. Both lavendustin A and PP2 did not affect cell viability per se (% of
control; controls: 100 7.8; lavendustin A: 104 9.2; PP2: 101 13.5). Values aremean
SE of six independent experiments: *p 0.05 IL-1 versus control; § p 0.05 IL-1 plus LAV or
plus PP2 versus IL-1; ANOVA followed by Tukey’s test.
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scription (Takasu et al., 2002). Thus, tyrosine phosphorylation of
the NMDA receptor appears to be relevant for regulating both
physiological and pathological processes involving glutamatergic
neurotransmission, and IL-1 may modulate both of these
pathways.
Recently it has been shown that the different subcellular local-
ization of NMDA receptors can be relevant in governing the ul-
timate neuronal fate. Thus, NMDA synaptic complexes promote
gene expression and cell survival, whereas NMDA extrasynaptic
complexes are involved in cell death (Hardingham et al., 2002).
We observed that (1) the effects of IL-1 on theNMDAreceptors
aremediated via IL-1RI and (2) IL-1RI is expressed withNR2A/B
receptor subunits in hippocampal neurons, suggesting a direct
functional cross-talk between IL1, IL-1RI, and the NMDA re-
ceptor. Although we did not address the subcellular localization
of IL-1RI and NR2A/B in this paper, it will be worth studying
whether IL-1modulates a pathological rather than a physiolog-
ical event by selectively enhancing the function of extrasynaptic
or synaptic NMDA receptors.
Our finding that IL-1 enhances NMDA-receptor function in
vitro is only in apparent contradiction with previous data report-
ing an inhibitory effect of this cytokine on NMDA receptor-
mediated EPSP (Coogan and O’Connor, 1997) and on excito-
toxic neuronal cell death (Strijbos and Rothwell, 1995; Pringle et
al., 2001). Thus, the effects of IL-1 on neurons depend on sev-
eral factors, including the functional state and the type of neu-
rons, the concentration of IL-1, and the duration of time that
the neuron is exposed to this cytokine. We indeed found a dual
effect of IL-1 on NMDA receptor function depending on its
concentration. Thus, relatively low concentrations of IL-1
(0.010.1 ng/ml) increased NMDA-receptor function, whereas
1 ng/ml had an inhibitory effect onNMDA-mediated increases in
[Ca2]i. These findings are compatible with previous evidence
showing that dose–response effects of IL-1 often display a bell-
shaped curve (Rothwell and Hopkins, 1995; Allan and Rothwell,
2001).
There is a major difference in the length of time that the neu-
rons were pre-exposed to IL-1 in our experimental conditions
showing exacerbation of neuronal death (i.e., 6 min) and previ-
ous evidence reporting inhibitory effects of IL-1 on neuronal
damage (i.e., 24 hr). Thus, exposure of neurons to IL-1 for 24 hr
before NMDA application or induction of injury may have in-
duced the synthesis and release from neurons of various factors
(i.e., anti-inflammatory cytokines, neuropeptides, growth fac-
tors) that in turn are responsible for changing neuronal suscep-
tibility to damage. In accordance, Strijbos and Rothwell (1995)
suggest that IL-1 reduction of excitatory amino acid-induced
neurodegeneration in vitro may be in part mediated via nerve
growth factor.
In summary, our findings show a novelmolecularmechanism
by which IL-1, a proinflammatory cytokine produced by both
glia and neurons in various CNS pathological conditions, may
significantly enhance NMDA receptor function. Pharmacologi-
cal intervention aimed at interfering with this cytokine pathway
may thus represent an innovative approach to control excessive
[Ca2]i increase in neurons and the consequent cascade of events
leading to neuronal hyperexcitability and irreversible cell injury.
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